Saturday 17 October 2026
Export SYK’s income statement to Excel — free account
Stryker Corporation
SYK Healthcare Medical Devices
Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.42%, EPS grew 43.1%, free cash flow grew 14.1% and total debt fell 9.88%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.
294.66
1.43
+0.49%
Follow SYK
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
14.04% | 15.08% | 15.20% | 16.51% | |
Piotroski F-Score |
4 | 5 | 7 | 7 | |
| 6.48% | 7.15% | 7.23% | 7.91% | ||
ROIC |
6.54% | 8.94% | 8.97% | 9.76% | |
Return on Tangible Assets |
29.34% | 29.95% | 30.59% | 31.89% | |
Average Days of Receivables |
54.54 | 58.70 | 51.58 | 52.88 | |
Free Cash Flow per Share |
11.08 | 11.21 | 11.94 | 12.26 | |
Free Cash Flow |
4,238.00 | 4,283.00 | 4,571.00 | 4,702.00 | |
Capital Expenditures |
(594.00) | (761.00) | (804.00) | (823.00) | |
| Other line items | |||||
Cash ROIC |
10.16% | 10.11% | 11.24% | 11.09% | |
Accounts Receivable Turnover |
6.61 | 6.26 | 6.71 | 6.75 | |
Accounts Payable Turnover |
6.19 | 5.20 | 5.98 | 5.83 | |
Inventory Turnover |
1.65 | 1.80 | 1.74 | 1.67 | |
Average Days of Payables |
62.35 | 72.55 | 63.58 | 67.08 | |
Days of Inventory on Hand |
223.49 | 214.14 | 216.43 | 222.69 | |
Tax Rate |
(0.12) | (0.28) | (0.27) | (0.28) | |
Research and Development Expense of Revenue |
6.48% | 6.46% | 6.45% | 6.42% | |
Selling, General and Administrative Expense of Revenue |
35.06% | 34.44% | 34.16% | 33.99% | |
Share Based Compensation of Revenue |
0.98% | 0.97% | 0.97% | 0.97% | |
Interest Coverage |
— | 7.86 | 6.61 | 7.29 | |
Operating CF/Net income |
1.64 | 1.55 | 1.61 | 1.48 | |
Depreciation/Fixed assets |
0.31 | 0.31 | 0.31 | 0.31 | |
Capex/Depreciation |
(0.52) | (0.64) | (0.66) | (0.67) | |
Revenue per Share |
63.76 | 65.71 | 66.00 | 67.37 | |
Operating CF per Share |
12.64 | 13.20 | 14.04 | 14.41 | |
Capex per Share |
(1.55) | (1.99) | (2.10) | (2.15) | |
Capex to Sales |
0.02 | 0.03 | 0.03 | 0.03 |
Columns are period end dates